Detection of Circulating Biomarkers of Immunogenic Cell Death

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

June 19, 2019

Study Completion Date

June 19, 2019

Conditions
Non Small Cell Lung Cancer
Interventions
OTHER

Blood withdrawal

For each patient, 3 blood withdrawals of 25 ml each will take place during treatment

Trial Locations (2)

3000

Unuversity Hospitals Leuven, Leuven

6229 ET

MAASTRO clinic, Maastricht

All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

lead

Maastricht Radiation Oncology

OTHER

NCT02921854 - Detection of Circulating Biomarkers of Immunogenic Cell Death | Biotech Hunter | Biotech Hunter